BEXJUXI
LIVE

Serial Number

79353036

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 23, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BEXJUXI Trademark

Serial Number: 79353036 • Registration: 6993998

BEXJUXI is a trademark filed by NOVARTIS AG on August 23, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 23, 2022

Registration Date

March 7, 2023

Published for Opposition

December 20, 2022

Cancellation Date

March 11, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Mar 26, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Mar 26, 2026 DETH
NOTIFICATION PROCESSED BY IB
May 9, 2023 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Apr 20, 2023 FICS
FINAL DISPOSITION PROCESSED
Apr 20, 2023 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 6, 2023 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 7, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 7, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Dec 22, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 20, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 30, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 30, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2022 CNSA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 7, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 7, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 7, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 7, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 7, 2022 COAR
ASSIGNED TO EXAMINER
Nov 7, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 1, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 27, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 20, 2022 REPR